source
- Full-Life Technologies raises $150M; Quince's reboot with pulmonary drugPlus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB. Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round an…Endpoints · 2mo ago↗ source
- STAT+: Dexcom CEO hints at future uses for CGMIn this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.STAT · 2mo ago↗ source
- STAT+: A new ranking of pharma companies by R&D performanceMaryland drug board to cap price of Ozempic, TrumpRx partners with Cuban, GoodRx, and more biotech newsSTAT · 2mo ago↗ source